At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CALC CALCIMEDICA
Trading 12-22 13:35:26 EST
6.18
-0.17
-2.68%
High6.37Low6.04Vol101.16K
Open6.35D1 Closing6.35Amplitude5.14%
Mkt Cap89.05MTradable Cap41.38MTotal Shares14.41M
T/O636.23KT/O Rate1.51%Tradable Shares6.70M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Oppenheimer Reaffirms Their Buy Rating on CalciMedica (CALC)
TIPRANKS  ·  11-17
Oppenheimer Reaffirms Their Buy Rating on CalciMedica (CALC)
CalciMedica reports Q3 net loss of $7.8 mln
Reuters  ·  11-12
CalciMedica reports Q3 net loss of $7.8 mln
CalciMedica Q3 EPS $(0.52) Misses $(0.42) Estimate
Benzinga  ·  11-12
CalciMedica Q3 EPS $(0.52) Misses $(0.42) Estimate
CalciMedica Launches Phase 2 KOURAGE Trial of Auxora in Acute Kidney Injury with Respiratory Failure
Reuters  ·  11-12
CalciMedica Launches Phase 2 KOURAGE Trial of Auxora in Acute Kidney Injury with Respiratory Failure
CalciMedica Reports Preclinical Success for CRAC Channel Inhibitor in Pulmonary Arterial Hypertension
Reuters  ·  11-12
CalciMedica Reports Preclinical Success for CRAC Channel Inhibitor in Pulmonary Arterial Hypertension
CalciMedica Q3 Operating Expenses USD 5.618 Million
THOMSON REUTERS  ·  11-12
CalciMedica Q3 Operating Expenses USD 5.618 Million
CalciMedica Q3 Basic EPS USD -0.52
THOMSON REUTERS  ·  11-12
CalciMedica Q3 Basic EPS USD -0.52
CalciMedica Inc - Cash Position Expected to Fund Operations Into 2H 2026
THOMSON REUTERS  ·  11-12
CalciMedica Inc - Cash Position Expected to Fund Operations Into 2H 2026
CalciMedica Reports Auxora Improves Kidney Function in Preclinical AKI Study
Reuters  ·  11-10
CalciMedica Reports Auxora Improves Kidney Function in Preclinical AKI Study
CalciMedica Inc expected to post a loss of 41 cents a share - Earnings Preview
Reuters  ·  11-07
CalciMedica Inc expected to post a loss of 41 cents a share - Earnings Preview
CalciMedica Boosts Stock Offering to $9.7 Million
TIPRANKS  ·  11-07
CalciMedica Boosts Stock Offering to $9.7 Million
CalciMedica and Telperian Announce AI Collaboration to Enhance Auxora Clinical Trial Analysis
Reuters  ·  10-14
CalciMedica and Telperian Announce AI Collaboration to Enhance Auxora Clinical Trial Analysis
CalciMedica Inc.'s Chief Business Officer Eric W. Roberts Reports Acquisition of Common Shares
Reuters  ·  09-23
CalciMedica Inc.'s Chief Business Officer Eric W. Roberts Reports Acquisition of Common Shares
CalciMedica’s CBO Makes Bold Stock Purchase!
TIPRANKS  ·  09-16
CalciMedica’s CBO Makes Bold Stock Purchase!
Eric W. Roberts, Chief Business Officer, Reports Acquisition of CalciMedica Inc. Common Shares
Reuters  ·  09-16
Eric W. Roberts, Chief Business Officer, Reports Acquisition of CalciMedica Inc. Common Shares
Eric W. Roberts, Chief Business Officer, Acquires Common Shares of CalciMedica Inc
Reuters  ·  09-12
Eric W. Roberts, Chief Business Officer, Acquires Common Shares of CalciMedica Inc
Eric W. Roberts, Chief Business Officer of CalciMedica Inc., Reports Acquisition of Common Shares
Reuters  ·  09-03
Eric W. Roberts, Chief Business Officer of CalciMedica Inc., Reports Acquisition of Common Shares
Eric W. Roberts, Chief Business Officer, Reports Acquisition of Common Shares in CalciMedica Inc
Reuters  ·  08-25
Eric W. Roberts, Chief Business Officer, Reports Acquisition of Common Shares in CalciMedica Inc
CalciMedica Inc.'s Chief Medical Officer Sudarshan Hebbar Reports Acquisition of Common Shares
Reuters  ·  08-22
CalciMedica Inc.'s Chief Medical Officer Sudarshan Hebbar Reports Acquisition of Common Shares
CalciMedica Inc. Chief Business Officer Eric W. Roberts Reports Acquisition of Common Shares
Reuters  ·  08-20
CalciMedica Inc. Chief Business Officer Eric W. Roberts Reports Acquisition of Common Shares

Introduction

Company Name.
CALCIMEDICA
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--